Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 17Hyperandrogenism 6Endometrial Neoplasms 4Breast Neoplasms 3Osteoporosis 2Endometrial Hyperplasia 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Obesity 1Menorrhagia 1Leiomyoma 1Infertility, Female 1Infertility 1Hot Flashes 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6Uterine Artery Embolization 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 4linzagolix 2Tranexamic Acid 2ziprasidone 1ulipristal acetate 1ulipristal 1pycnogenols 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiofrequency Ablation 1Progesterone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Menorrhagia × Progesterone × Clear all
NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed
271 enrolled 38 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡